Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

Here's what happened, and why it's bullish for Lilly's stock.

Cheesecake Factory gains after report activist pushing for breakup. Lilly sues companies selling compounded Zepbound, ...

The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of ...

Detailed price information for Inmed Pharmaceuticals Inc (INM-Q) from The Globe and Mail including charting and trades.

Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

Fintel reports that on October 21, 2024, EF Hutton initiated coverage of NRx Pharmaceuticals (NasdaqCM:NRXP) with a Buy ...

The global GLP-1 receptor agonist market is poised for extraordinary expansion, driven by an increase in therapeutic applications and favorable market projections. Recent analysis indicates a ...

Northwestern Medicine surgeons say, head to head, bariatric surgery is more cost effective for patients, employers and ...